Apogee Therapeutics operates as a specialized, streamlined clinical-stage biopharmaceutical firm supported by a lean, highly skilled professional workforce numbering approximately 337 employees. This personnel base comprises expert scientists, clinical research coordinators, regulatory compliance specialists, and executive management teams distributed primarily across core operational hubs in San Francisco and Boston.